Published June 2018
| Version v1
Journal article
Whole-body diffusion-weighted MR and FDG-PET/CT in Hodgkin Lymphoma: Predictive role before treatment and early assessment after two courses of ABVD
Creators
- 1. Department of Radiology, Di.Bi.Med, University of Palermo, Via del Vespro 127, 90127 Palermo (Italy)
- 2. Department of Hematology I, Azienda Ospedali Riuniti Villa Sofia-Cervello, Viale Trabucco 180, 90146 Palermo (Italy)
- 3. Department of Sciences for Health Promotion and Mother and Child Care "G. D'Alessandro", University of Palermo, Via del Vespro 133, 90127 Palermo (Italy)
Description
Highlights: • Baseline-SUVmax and ADC cannot predict response after two ABVD in Hodgkin Lymphoma. • Bulky is a useful imaging parameter to predict suboptimal response to ABVD. • Interim ADC is useful to differentiate responder from non-responder lesions. • Size changes are not helpful in evaluating the response to ABVD. • Whole-body MR could be useful to assess the early response to chemotherapy. - Abstract: Purpose: To evaluate whether imaging features of pathologic lymph nodes on whole-body diffusion-weighted MR have a predictive role before treatment and may assess the response after two courses of chemotherapy in comparison to FDG-PET/CT in Hodgkin Lymphoma.
Availability note (English)
Available from http://dx.doi.org/10.1016/j.ejrad.2018.04.014Additional details
Identifiers
- DOI
- 10.1016/j.ejrad.2018.04.014;
- PII
- S0720048X18301402;
Publishing Information
- Journal Title
- European Journal of Radiology
- Journal Volume
- 103
- Journal Page Range
- p. 90-98
- ISSN
- 0720-048X
- CODEN
- EJRADR
INIS
- Country of Publication
- Netherlands
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 51001036
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- CHEMOTHERAPY; COMPARATIVE EVALUATIONS; DIFFUSION; LYMPH NODES; LYMPHOMAS; POSITRON COMPUTED TOMOGRAPHY
- Descriptors DEC
- COMPUTERIZED TOMOGRAPHY; DIAGNOSTIC TECHNIQUES; DISEASES; EMISSION COMPUTED TOMOGRAPHY; EVALUATION; IMMUNE SYSTEM DISEASES; LYMPHATIC SYSTEM; MEDICINE; NEOPLASMS; THERAPY; TOMOGRAPHY
Optional Information
- Notes
- © 2018 Elsevier B.V. All rights reserved.